Status:
COMPLETED
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
Lead Sponsor:
Creative Biosciences (Guangzhou) Co., Ltd.
Conditions:
Colorectal Cancer
Advanced Adenocarcinoma
Eligibility:
All Genders
40-79 years
Brief Summary
According to data from Global Cancer Statistics 2018, colorectal cancer (CRC) ranks second in incidence and fifth in mortality among all cancers in China. The underlying neoplastic progression from ad...
Detailed Description
The multicenter clinical trial will be conducted using a single-blind method. Stool samples provided by participants will be evaluated by Human Multigene Methylation Detection Kit (Fluorescent PCR). T...
Eligibility Criteria
Inclusion
- Participants must also meet the following three criteria to be included in this study:
- To be 40 to 79 years old, regardless of gender;
- To participate voluntarily and sign Informed Consent Form;
- To satisfy any of the following three conditions:
- Patients with colorectal cancer confirmed or suspected by colonoscopy or pathological biopsy;
- Patients with gastrointestinal disease or normal population to be examined by colonoscopy;
- Patients who are planning to undergo colonoscopy or have colonoscopy results from other interfering diseases.
Exclusion
- Patients with any of the following conditions shall be excluded:
- To have had radical resection of colorectal cancer before enrollment in this study;
- To have been deemed ineligible to participate in the study by the principal investigator due to various other reasons.
Key Trial Info
Start Date :
January 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2022
Estimated Enrollment :
1273 Patients enrolled
Trial Details
Trial ID
NCT04722055
Start Date
January 26 2021
End Date
August 8 2022
Last Update
October 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong Cancer Hospital and Institute
Jinan, Shandong, China